Cinctive Capital Management’s Revolution Medicines RVMD Stock Holding History

Cinctive Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.99M	Sell	26,661 -67,196	-72%	-$9.82M	0.18%	171
2026 Q1	$9.13M	Buy	93,857 +51,222	+120%	+$5.17M	0.59%	45
2025 Q4	$3.4M	Buy	+42,635	New	+$2.8M	0.18%	153
2025 Q2	–	Sell	-11,343	Closed	-$401K	–	458
2025 Q1	$401K	Sell	11,343 -23,447	-67%	-$952K	0.03%	272
2024 Q4	$1.52M	Sell	34,790 -18,571	-35%	-$937K	0.08%	248
2024 Q3	$2.42M	Buy	53,361 +30,430	+133%	+$1.33M	0.13%	212
2024 Q2	$890K	Sell	22,931 -15,230	-40%	-$569K	0.04%	323
2024 Q1	$1.23M	Sell	38,161 -26,947	-41%	-$799K	0.06%	268
2023 Q4	$1.87M	Buy	+65,108	New	+$1.56M	0.12%	191

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Cinctive Capital Management's RVMD Position: Q2 2026 in Review

Cinctive Capital Management reduced its Revolution Medicines (RVMD) stake by 72% in Q2 2026, selling an estimated $9.82M and leaving 26,661 shares worth $4.99M. The position accounts for 0.18% of the portfolio, ranked #171.

Cinctive Capital Management first reported a position in RVMD in Q4 2023 and has held it in 9 quarters since. The position peaked at $9.13M in Q1 2026. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Cinctive Capital Management held 26,661 shares of Revolution Medicines worth $4.99M as of Q2 2026.
Cinctive Capital Management sold 67,196 Revolution Medicines shares in Q2 2026, an estimated $9.82M.
Revolution Medicines made up 0.18% of Cinctive Capital Management's portfolio in Q2 2026, its #171 holding.
Cinctive Capital Management first reported a position in Revolution Medicines in Q4 2023 and has held it in 9 quarters since.
Cinctive Capital Management's Revolution Medicines position peaked at $9.13M in Q1 2026.
691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.